ROCKWELL MEDICAL, INC. Proceeds from Sale of Productive Assets
ROCKWELL MEDICAL, INC. (RMTI) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2020-03-17
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for the quarter ending 2017-12-31 was $275.00.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for the quarter ending 2017-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for the quarter ending 2017-06-30 was $0.00.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for the quarter ending 2017-03-31 was $450.00.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for fiscal 2018 was $400.00, a 44.83% decline from fiscal 2017.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for fiscal 2017 was $725.00, a 27.50% decline from fiscal 2016.
- ROCKWELL MEDICAL, INC. proceeds from sale of productive assets for fiscal 2016 was $1.00K, a 79.17% decline from fiscal 2015.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-17 | |||
| 2018-12-31 | $400.00 10-K · filed 2020-03-17 | |||
| 2017-12-31 | $275.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $275.00 derived: sum of 2 quarters · filed 2019-03-18 | $275.00 derived: sum of 3 quarters · filed 2019-03-18 | $725.00 10-K · filed 2019-03-18 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $450.00 10-Q · filed 2018-11-09 | $450.00 derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-14 | $450.00 10-Q · filed 2018-08-14 | $450.00 derived: sum of 3 quarters · filed 2018-08-14 | $450.00 derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $450.00 10-Q/A · filed 2018-08-14 | $450.00 derived: sum of 2 quarters · filed 2018-08-14 | $450.00 derived: sum of 3 quarters · filed 2018-08-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $1.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.00K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $1.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $4.80K 10-K · filed 2018-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $4.80K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.80K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $4.80K 10-Q · filed 2016-05-10 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $900.00 derived: sum of 3 quarters · filed 2016-02-29 | $6.90K 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $900.00 derived: sum of 2 quarters · filed 2014-11-10 | $6.90K 10-Q · filed 2014-11-10 | $6.90K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $900.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $6.90K 10-Q · filed 2014-07-31 | $6.90K derived: sum of 3 quarters · filed 2015-03-03 | $6.90K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $6.00K 10-Q · filed 2014-05-12 | $6.00K derived: sum of 2 quarters · filed 2015-03-03 | $6.00K derived: sum of 3 quarters · filed 2015-03-03 | $7.23K derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $0.00 derived: sum of 2 quarters · filed 2015-03-03 | $1.23K derived: sum of 3 quarters · filed 2015-03-03 | $1.58K 10-K · filed 2015-03-03 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $1.23K derived: sum of 2 quarters · filed 2013-11-05 | $1.58K 10-Q · filed 2013-11-05 | |
| 2012-06-30 | $1.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $1.58K 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | $350.00 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $2.98K 10-K · filed 2014-03-07 | |||
| 2010-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.80K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $800.00 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $800.00 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |